4//SEC Filing
Dake Benjamin T 4
Accession 0001415889-24-009243
CIK 0001798749other
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 6:00 PM ET
Size
9.2 KB
Accession
0001415889-24-009243
Insider Transaction Report
Form 4
Dake Benjamin T
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-03-25$10.61/sh+3,432$36,414→ 4,723 total - Sale
Common Stock
2024-03-25$28.01/sh−3,432$96,119→ 1,291 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-03-25−3,432→ 40,068 totalExercise: $10.61Exp: 2031-12-13→ Common Stock (3,432 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.95 to $28.385, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]A total of 58,000 shares subject to an employee stock option were granted on December 14, 2021, with the first installment vested on January 14, 2022, and with shares vesting in 48 substantially equal monthly installments.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001869248
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 6:00 PM ET
- Size
- 9.2 KB